Warburg Pincus related stories
All articles and analysis
Baxter International to divest BioPharma Solutions business to Advent and Warburg Pincus for $4.2bnThe deal is expected to close in the second half of 2023.
Ten emerging managers to keep your eye on in 2023Buyouts has identified 10 intriguing first timers that are today braving a brutal fundraising market. Reflecting an array of backgrounds and strategies, we plan to keep close tabs on them in the months ahead.
Future 40 Leaders – 2023: Dealmakers40 under 40: Future Leaders of Private Equity. Meet the dealmakers demonstrating innovation, drive and forward thinking.
Warburg Pincus-backed BlueGrace Logistics recruits Bly as carrier relations senior directorTampa, Florida-based BlueGrace is a third-party logistics provider.
PE-backed GHX to buy healthcare supply chain company ProdigoLouisville, Colorado-based GHX is a provider of connected, intelligent healthcare supply chains.
Warburg’s Ruoxi Chen talks Polyplus and 'creative' exit marketChen said Warburg Pincus was still investing 'substantially' in Polyplus only few months before the exit.
Warburg Pincus recruits Gabriel as senior advisor for industrials groupIn his role, Gabriel will work with Warburg Pincus to identify and evaluate new investment opportunities in distribution and other sectors.
Side Letter: KKR's $8bn close; 5x continuation vindication; CalSTRS' two-pronged climate planKKR has closed its latest European flagship. Plus: How CalSTRS aims to deploy billions into climate investing; and the SEC is taking a closer look at third-party valuations. Here’s today's brief, for our valued subscribers only.
ArchiMed scores 300x return for debut fund with Polyplus exitArchiMed and Warburg Pincus have agreed to sell the France-headquartered business to life science group Sartorius for approximately €2.4bn.
Deal of the Year: KKR's exit of CHI Overhead DoorsKKR does well by doing good as it shares the wealth with workers and CHI as part of its employee ownership program.